Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA03020054 16-carboxy-17,18,19,20-tetranor-leukotriene E3 (5Z,7E,9E,11R,12S)-11-(L-cystein-S-yl)-12-hydroxyhexadeca-5,7,9-trienedioic acid;(5Z,7E,9E,11R,12S)-11-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-12-hydroxyhexadeca-5,7,9-trienedioic acid C19H29NO7S 415.166475
LMFA03020054 16-carboxy-17,18,19,20-tetranor-leukotriene E3 (5Z,7E,9E,11R,12S)-11-(L-cystein-S-yl)-12-hydroxyhexadeca-5,7,9-trienedioic acid;(5Z,7E,9E,11R,12S)-11-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-12-hydroxyhexadeca-5,7,9-trienedioic acid C19H29NO7S 415.166475
LMFA03020054 16-carboxy-17,18,19,20-tetranor-leukotriene E3 (5Z,7E,9E,11R,12S)-11-(L-cystein-S-yl)-12-hydroxyhexadeca-5,7,9-trienedioic acid;(5Z,7E,9E,11R,12S)-11-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-12-hydroxyhexadeca-5,7,9-trienedioic acid C19H29NO7S 415.166475
LMFA03020055 16-carboxy-Delta(13)-17,18,19,20-tetranor-leukotriene E4 (5Z,7E,9E,11R,12S)-11-(L-cystein-S-yl)-12-hydroxyhexadeca-3,5,7,9-tetraenedioic acid;(5Z,7E,9E,11R,12S)-11-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-12-hydroxyhexadeca-3,5,7,9-tetraenedioic acid C19H27NO7S 413.150825
LMFA03020055 16-carboxy-Delta(13)-17,18,19,20-tetranor-leukotriene E4 (5Z,7E,9E,11R,12S)-11-(L-cystein-S-yl)-12-hydroxyhexadeca-3,5,7,9-tetraenedioic acid;(5Z,7E,9E,11R,12S)-11-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-12-hydroxyhexadeca-3,5,7,9-tetraenedioic acid C19H27NO7S 413.150825
LMFA03020055 16-carboxy-Delta(13)-17,18,19,20-tetranor-leukotriene E4 (5Z,7E,9E,11R,12S)-11-(L-cystein-S-yl)-12-hydroxyhexadeca-3,5,7,9-tetraenedioic acid;(5Z,7E,9E,11R,12S)-11-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-12-hydroxyhexadeca-3,5,7,9-tetraenedioic acid C19H27NO7S 413.150825
LMFA03020056 18-carboxy-19,20-dinor-leukotriene E4 (4Z,7Z,9E,11E,13R,14S)-13-(L-cystein-S-yl)-14-hydroxyoctadeca-4,7,9,11-tetraenedioic acid;(4Z,7Z,9E,11E,13R,14S)-13-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-14-hydroxyoctadeca-4,7,9,11-tetraenedioic acid C21H31NO7S 441.182125
LMFA03020056 18-carboxy-19,20-dinor-leukotriene E4 (4Z,7Z,9E,11E,13R,14S)-13-(L-cystein-S-yl)-14-hydroxyoctadeca-4,7,9,11-tetraenedioic acid;(4Z,7Z,9E,11E,13R,14S)-13-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-14-hydroxyoctadeca-4,7,9,11-tetraenedioic acid C21H31NO7S 441.182125
LMFA03020056 18-carboxy-19,20-dinor-leukotriene E4 (4Z,7Z,9E,11E,13R,14S)-13-(L-cystein-S-yl)-14-hydroxyoctadeca-4,7,9,11-tetraenedioic acid;(4Z,7Z,9E,11E,13R,14S)-13-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-14-hydroxyoctadeca-4,7,9,11-tetraenedioic acid C21H31NO7S 441.182125
LMFA03020059 20-COOH-10,11-dihydro-LTB4 (5R,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,14-trienedioic acid FA 20:4;O4 C20H32O6 368.219891
LMFA03020059 20-COOH-10,11-dihydro-LTB4 (5R,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,14-trienedioic acid FA 20:4;O4 C20H32O6 368.219891
LMFA03020060 20-COOH-leukotriene E4 (6Z,9Z,11E,13E,15R,16S)-15-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}-16-hydroxyicosa-6,9,11,13-tetraenedioic acid C23H35NO7S 469.213425
LMFA03020060 20-COOH-leukotriene E4 (6Z,9Z,11E,13E,15R,16S)-15-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}-16-hydroxyicosa-6,9,11,13-tetraenedioic acid C23H35NO7S 469.213425
LMFA03020060 20-COOH-leukotriene E4 (6Z,9Z,11E,13E,15R,16S)-15-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}-16-hydroxyicosa-6,9,11,13-tetraenedioic acid C23H35NO7S 469.213425
LMFA03020061 20-dihydroxyleukotriene B4 (5R,6Z,8E,10E,12S,14Z)-5,12,20,20-tetrahydroxyicosa-6,8,10,14-tetraenoic acid FA 20:4;O4 C20H32O6 368.219891
LMFA03020061 20-dihydroxyleukotriene B4 (5R,6Z,8E,10E,12S,14Z)-5,12,20,20-tetrahydroxyicosa-6,8,10,14-tetraenoic acid FA 20:4;O4 C20H32O6 368.219891
LMFA03020064 20-oxo-leukotriene B4 (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxy-20-oxoicosa-6,8,10,14-tetraenoic acid FA 20:5;O3 C20H30O5 350.209326
LMFA03020064 20-oxo-leukotriene B4 (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxy-20-oxoicosa-6,8,10,14-tetraenoic acid FA 20:5;O3 C20H30O5 350.209326
LMFA03020065 20-Oxo-leukotriene E4 (5S,6R,7E,9E,11Z,14Z)-6-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}-5-hydroxy-20-oxoicosa-7,9,11,14-tetraenoic acid C23H35NO6S 453.218510
LMFA03020065 20-Oxo-leukotriene E4 (5S,6R,7E,9E,11Z,14Z)-6-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}-5-hydroxy-20-oxoicosa-7,9,11,14-tetraenoic acid C23H35NO6S 453.218510
LMFA03020065 20-Oxo-leukotriene E4 (5S,6R,7E,9E,11Z,14Z)-6-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}-5-hydroxy-20-oxoicosa-7,9,11,14-tetraenoic acid C23H35NO6S 453.218510
LMFA03020066 20-Trihydroxy-leukotriene-B4 (5R,6Z,8E,10E,12S,14Z)-5,12,20,20,20-pentahydroxyicosa-6,8,10,14-tetraenoic acid FA 20:4;O5 C20H32O7 384.214806
LMFA03020066 20-Trihydroxy-leukotriene-B4 (5R,6Z,8E,10E,12S,14Z)-5,12,20,20,20-pentahydroxyicosa-6,8,10,14-tetraenoic acid FA 20:4;O5 C20H32O7 384.214806
LMFA03020068 5(6)-Epoxy Prostaglandin E1 4-(3-{[(1S,2S,3S)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]methyl}oxiran-2-yl)butanoic acid FA 20:4;O4 C20H32O6 368.219891
LMFA03020068 5(6)-Epoxy Prostaglandin E1 4-(3-{[(1S,2S,3S)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]methyl}oxiran-2-yl)butanoic acid FA 20:4;O4 C20H32O6 368.219891
LMFA03020068 5(6)-Epoxy Prostaglandin E1 4-(3-{[(1S,2S,3S)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]methyl}oxiran-2-yl)butanoic acid FA 20:4;O4 C20H32O6 368.219891
LMFA03020068 5(6)-Epoxy Prostaglandin E1 4-(3-{[(1S,2S,3S)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]methyl}oxiran-2-yl)butanoic acid FA 20:4;O4 C20H32O6 368.219891
LMFA03020069 5-Oxo-6-trans-leukotriene B4 (6E,8E,10E,12R,14Z)-12-hydroxy-5-oxoicosa-6,8,10,14-tetraenoic acid FA 20:5;O2 C20H30O4 334.214411
LMFA03020069 5-Oxo-6-trans-leukotriene B4 (6E,8E,10E,12R,14Z)-12-hydroxy-5-oxoicosa-6,8,10,14-tetraenoic acid FA 20:5;O2 C20H30O4 334.214411
LMFA03020069 5-Oxo-6-trans-leukotriene B4 (6E,8E,10E,12R,14Z)-12-hydroxy-5-oxoicosa-6,8,10,14-tetraenoic acid FA 20:5;O2 C20H30O4 334.214411
LMFA03020070 6,7-dihydro-12-epi-LTB4 (5R,8E,10E,12R,14Z)-5,12-dihydroxyicosa-8,10,14-trienoic acid FA 20:3;O2 C20H34O4 338.245711
LMFA03020070 6,7-dihydro-12-epi-LTB4 (5R,8E,10E,12R,14Z)-5,12-dihydroxyicosa-8,10,14-trienoic acid FA 20:3;O2 C20H34O4 338.245711
LMFA03020071 6,7-dihydro-5-oxo-12-epi-LTB4 (8E,10E,12R,14Z)-12-hydroxy-5-oxoicosa-8,10,14-trienoic acid FA 20:4;O2 C20H32O4 336.230061
LMFA03020071 6,7-dihydro-5-oxo-12-epi-LTB4 (8E,10E,12R,14Z)-12-hydroxy-5-oxoicosa-8,10,14-trienoic acid FA 20:4;O2 C20H32O4 336.230061
LMFA03020071 6,7-dihydro-5-oxo-12-epi-LTB4 (8E,10E,12R,14Z)-12-hydroxy-5-oxoicosa-8,10,14-trienoic acid FA 20:4;O2 C20H32O4 336.230061
LMFA03020072 Delta(6)-trans,Delta(8)-cis-leukotriene B4 (5S,6E,8Z,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid FA 20:4;O2 C20H32O4 336.230061
LMFA03020072 Delta(6)-trans,Delta(8)-cis-leukotriene B4 (5S,6E,8Z,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid FA 20:4;O2 C20H32O4 336.230061
LMFA03020073 Leukotriene D5 5R-hydroxy-6S-(S-cysteinylglycinyl)-7E,9E,11Z,14Z,17Z-eicosapentenoic acid C25H38N2O6S 494.245059
LMFA03020073 Leukotriene D5 5R-hydroxy-6S-(S-cysteinylglycinyl)-7E,9E,11Z,14Z,17Z-eicosapentenoic acid C25H38N2O6S 494.245059
LMFA03020074 Leukotriene E3 (5S,6R,7E,9E,11Z)-6-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-5-hydroxyicosa-7,9,11-trienoic acid C23H39NO5S 441.254895
LMFA03020074 Leukotriene E3 (5S,6R,7E,9E,11Z)-6-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-5-hydroxyicosa-7,9,11-trienoic acid C23H39NO5S 441.254895
LMFA03020074 Leukotriene E3 (5S,6R,7E,9E,11Z)-6-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-5-hydroxyicosa-7,9,11-trienoic acid C23H39NO5S 441.254895
LMFA03040010 15-epi-lipoxin A4 (5S,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03040010 15-epi-lipoxin A4 (5S,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03040011 15-Oxo-lipoxin A4 (5R,6R,7E,9E,11Z,13E)-5,6-dihydroxy-15-oxoicosa-7,9,11,13-tetraenoic acid FA 20:5;O3 C20H30O5 350.209326
LMFA03040011 15-Oxo-lipoxin A4 (5R,6R,7E,9E,11Z,13E)-5,6-dihydroxy-15-oxoicosa-7,9,11,13-tetraenoic acid FA 20:5;O3 C20H30O5 350.209326
LMFA03040011 15-Oxo-lipoxin A4 (5R,6R,7E,9E,11Z,13E)-5,6-dihydroxy-15-oxoicosa-7,9,11,13-tetraenoic acid FA 20:5;O3 C20H30O5 350.209326
LMFA03030015 Thromboxane (2R,3S)-3-heptyl-2-octyloxane FA 20:0;O C20H40O 296.307916
LMFA03030016 Thromboxane B3 (5E)-7-{4,6-dihydroxy-2-[(1E,5E)-3-hydroxyocta-1,5-dien-1-yl]oxan-3-yl}hept-5-enoic acid FA 20:4;O4 C20H32O6 368.219891
LMFA03030016 Thromboxane B3 (5E)-7-{4,6-dihydroxy-2-[(1E,5E)-3-hydroxyocta-1,5-dien-1-yl]oxan-3-yl}hept-5-enoic acid FA 20:4;O4 C20H32O6 368.219891